Acute respiratory distress syndrome (ARDS) is a serious condition characterised by widespread inflammation in the lungs and represents a major cause of morbidity and mortality in the critical care setting. Here the Clinical Operations team at Cell and Gene Therapy Catapult and Anthony Ting, Vice President of Regenerative Medicine, Athersys inc. discuss the ongoing clinical study using Multistem to treat ARDS.